REMORGIDA, VALENTINO
 Distribuzione geografica
Continente #
EU - Europa 24.561
Totale 24.561
Nazione #
IT - Italia 24.561
Totale 24.561
Città #
Genova 20.412
Rapallo 2.013
Genoa 1.627
Vado Ligure 449
Bordighera 60
Totale 24.561
Nome #
Bowel preparation before laparoscopic gynaecological surgery in benign conditions using a 1-week low fibre diet: a surgeon blind, randomized and controlled trial. 171
Antiangiogenic therapies in endometriosis. 155
Ureteral Suspension Facilitates Surgery for Deep Pelvic Endometriosis 152
Multislice CT enteroclysis in the diagnosis of bowel endometriosis. 146
What is the desired menstrual frequency of women without menstruation-related symptoms? 145
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 145
Triptorelin for the treatment of endometriosis. 144
Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation 143
Haptoglobin concentration in peritoneal fluid of women with endometriosis 140
Emostasi attraverso elettrocoagulazione con corrente bipolare oppure sutura laparoscopica dopo escissione chirurgica di endometriomi ovarici bilaterali: studio prospettico randomizzato 140
Dedifferrentiated endometrioid adenocarcinoma: report of an highly aggressive lethal case and review of literature. 140
Triptorelin improves intestinal symptoms among patients with colorectal endometriosis. 139
Atherosclerosis in Women With Endometriosis. 136
OC13.01: Intraoperative ultrasonography during laparoscopic myomectomy 136
Abdominal pain, bloating, and urgency. 136
Bowel endometriosis: CT-enteroclysis. 133
Drug safety evaluation of desogestrel 133
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura 132
Desogestrel only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study 131
Proteomics technologies in endometriosis 130
Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives 130
L'enteroclisi-TC multistrato del colon (E-TCMS) associata alla tecnica "split-bolus": metodica integrata per la valutazione degli ureteri in donne con endometriosi intestinale 129
Endometriosis and irritable bowel syndrome: co-morbidity or misdiagnosis? 129
Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura 129
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review 129
Vaginal sacrospinous colpopexy using the Capio suture-capturing device versus traditional technique: feasibility and outcome 129
Future perspectives in the medical treatment of endometriosis. 128
Fertility after bowel resection for endometriosis. 128
Bowel endometriosis: Recent insights and unsolved problems 127
Asthma in women with endometriosis 126
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 126
Total and active ghrelin levels in women with polycystic ovary syndrome. 125
Body mass index in endometriosis. 124
How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study 124
Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device 124
The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis. 123
Proteomic analysis of peritoneal fluid in women with endometriosis. 123
Multidetector computerized tomography enema versus magnetic resonance enema in the diagnosis of rectosigmoid endometriosis 123
Endometriosis at 2nd surgery--residual or recurrent disease. 123
MDCT Enteroclysis Urography With Split-Bolus Technique Provides Information on Ureteral Involvement in Patients With Suspected Bowel Endometriosis 121
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot. 121
Aromatase inhibitors in the treatment of bladder endometriosis 120
Atherosclerosis in women with endometriosis. 120
Asthma in women with endometriosis. 119
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. 119
Endometriosis presenting with hemorrhagic ascites 119
Deep dyspareunia: causes, treatments, and results. 118
Proteomic patterns in plasma and peritoneal fluid of women with endometriosis. 118
Vaginal danazol in women with rectovaginal endometriosis and pain symptoms persisting after the insertion of the levonorgestrel-releasing intrauterine device. 118
Transvaginal ultrasonography combined with water-contrast in the rectum in the diagnosis of rectovaginal endometriosis infiltrating the bowel. 118
Migraine in women with endometriosis. 117
"Triple marker" for ectopic pregnancy. 116
Ki-67, bcl-2, and M30 CytoDEATH in endometriotic lesions. 116
Prevalence of newly diagnosed endometriosis in women attending the general practitioner. 116
Dyspareunia and Quality of Sex Life After Laparoscopic Excision of Endometriosis. 115
Bowel endometriosis: presentation, diagnosis, and treatment. 115
Uterine myomas, dyspareunia, and sexual function. 115
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study 114
Aromatase and endometriosis: estrogens play a role 114
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. 114
Letrozole and norethisterone acetate in rectovaginal endometriosis. 113
Dienogest in the treatment of endometriosis. 113
TMNSC: a new predictor of pregnancy after IUI 113
Images of children born following infertility treatment. 113
Proteomics technologies in endometriosis. 112
Luteinizing hormone determinations obtained with either a monoclonal and a polyclonal antibody radioimmunoassay and their correlations with clinical findings 112
Deep dyspareunia and sex life after laparoscopic excision of endometriosis. 112
Quality of sex life in women with endometriosis and deep dyspareunia. 112
Loss of sympathetic nerve fibers in intestinal endometriosis. 111
Current pharmacotherapy for endometriosis. 110
State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature 110
A successful healthy childbirth and an ongoing evolutive pregnancy in a case of partial globozoospermia by hyaluronic acid sperm selection 109
Irritable bowel syndrome and endometriosis. 108
Prevalence of depression in women with endometriosis. 108
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females 108
Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation 108
Hemostasis by Bipolar Coagulation Versus Suture After Surgical Stripping of Bilateral Ovarian Endometriomas: A Randomized Controlled Trial 108
Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization 108
Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. 107
Seasonal variations in sperm parameters. 107
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura 107
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study 107
Does transvaginal ultrasonography combined with water-contrast in the rectum aid in the diagnosis of rectovaginal endometriosis infiltrating the bowel? 107
Letrozole monotherapy in the treatment of uterine myomas. 106
Diagnosis of bowel endometriosis: A review 106
Unusual complication of excision of pelvic endometriosis: pseudoaneurysm of the left uterine artery. 106
Self-reported sleep quality in women with endometriosis 106
Ureteral suspension facilitates surgery for deep pelvic endometriosis. 105
Thyroid Disorders in Women With Endometriosis. 105
Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation 105
Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study 105
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis 105
3-Month Versus 6-Month Treatment With Ulipristal Acetate Prior to Laparoscopic Hysterectomy of Large Myomatous Uteri 105
Non-invasive mitochondrial DNA quantification on day 3 predicts blastocyst development: a prospective, blinded, multi-centric study 105
Vitamin D binding protein in endometriosis. 105
Reply: Diagnosis of rectovaginal endometriosis 104
Biochemical markers of atherosclerosis in women with endometriosis. 104
Surgical versus hormonal treatment of focal uterine adenomyosis: open-label patient preference trial 104
Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation. 103
Endometriosis in menopause: a single institution experience 103
Totale 11.994
Categoria #
all - tutte 65.469
article - articoli 46.051
book - libri 0
conference - conferenze 18.870
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 548
Totale 130.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.161 0 0 427 549 716 854 1.110 503 699 1.211 734 358
2020/20211.911 109 237 174 167 91 188 96 183 177 213 139 137
2021/20223.107 76 191 215 360 167 176 249 766 97 308 104 398
2022/20232.455 259 150 49 238 401 479 11 155 422 18 226 47
2023/20241.217 71 204 39 130 101 164 64 93 71 50 53 177
2024/2025484 69 350 65 0 0 0 0 0 0 0 0 0
Totale 24.779